Solanezumab and the amyloid hypothesis for Alzheimer’s disease
Year: 2016
Type: editorial
Abstract: Solanezumab’s failure is a wake-up call to look elsewhere for an answer to dementia
Source: BMJ
DOI: 10.1136/bmj.i6771
Authors: David G Le Couteur, Sally Hunter, Carol Brayne
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2566007025
